These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
764 related articles for article (PubMed ID: 30282320)
1. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling. Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320 [TBL] [Abstract][Full Text] [Related]
2. Monofunctional dimetallic Ru(η6-arene) complexes inhibit NOTCH1 signaling pathway and synergistically enhance anticancer effect in combination with cisplatin or vitamin C. Wang N; Ali A; Liu Z; Chi H; Lv Z; Zhao X; Zhang Z; Hao H; Zhang Y; Rahman FU Eur J Med Chem; 2023 Oct; 258():115536. PubMed ID: 37295260 [TBL] [Abstract][Full Text] [Related]
3. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli. Rahman FU; Ali A; Khan IU; Duong HQ; Yu SB; Lin YJ; Wang H; Li ZT; Zhang DW Eur J Med Chem; 2017 May; 131():263-274. PubMed ID: 28334655 [TBL] [Abstract][Full Text] [Related]
4. Anticancer activity and mechanism of bis-pyrimidine based dimetallic Ru(II)(η Bhatti MZ; Ali A; Duong HQ; Chen J; Rahman FU J Inorg Biochem; 2019 May; 194():52-64. PubMed ID: 30831390 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and cytotoxic activities of organometallic Ru(II) diamine complexes. Kavukcu SB; Şahin O; Seda Vatansever H; Kurt FO; Korkmaz M; Kendirci R; Pelit L; Türkmen H Bioorg Chem; 2020 Jun; 99():103793. PubMed ID: 32278205 [TBL] [Abstract][Full Text] [Related]
7. Design of Ru-arene Complexes for Antitumor Drugs. Su W; Li Y; Li P Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728 [TBL] [Abstract][Full Text] [Related]
12. New organoruthenium compounds with pyrido[2',3':5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action. Pavlović M; Nikolić S; Gligorijević N; Dojčinović B; Aranđelović S; Grgurić-Šipka S; Radulović S J Biol Inorg Chem; 2019 Mar; 24(2):297-310. PubMed ID: 30762123 [TBL] [Abstract][Full Text] [Related]
13. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features. Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963 [TBL] [Abstract][Full Text] [Related]
14. Activation by Oxidation: Ferrocene-Functionalized Ru(II)-Arene Complexes with Anticancer, Antibacterial, and Antioxidant Properties. Mu C; Prosser KE; Harrypersad S; MacNeil GA; Panchmatia R; Thompson JR; Sinha S; Warren JJ; Walsby CJ Inorg Chem; 2018 Dec; 57(24):15247-15261. PubMed ID: 30495936 [TBL] [Abstract][Full Text] [Related]
15. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands. Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401 [TBL] [Abstract][Full Text] [Related]
16. The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity. Caruso F; Pettinari R; Rossi M; Monti E; Gariboldi MB; Marchetti F; Pettinari C; Caruso A; Ramani MV; Subbaraju GV J Inorg Biochem; 2016 Sep; 162():44-51. PubMed ID: 27293144 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction. Jadhav GR; Sinha S; Chhabra M; Paira P Bioorg Med Chem Lett; 2016 Jun; 26(11):2695-700. PubMed ID: 27090558 [TBL] [Abstract][Full Text] [Related]
18. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes. Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042 [TBL] [Abstract][Full Text] [Related]
19. Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: synthesis, characterisation and preliminary evaluation of biological activity. Ji L; Zheng W; Lin Y; Wang X; Lü S; Hao X; Luo Q; Li X; Yang L; Wang F Eur J Med Chem; 2014 Apr; 77():110-20. PubMed ID: 24631730 [TBL] [Abstract][Full Text] [Related]
20. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands. Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]